Showing results (271-280 of 309) with videos related to
Sort By:
Pageof 31
Bladder Cancer (Amsterdam, Netherlands)|August 22, 2025
Small cell carcinoma of the bladder: Review of pathogenesis, presentation, and managementNicholas I Simon, Andre R Kydd, Dilara Akbulut, et al.Bladder Cancer (Amsterdam, Netherlands)|December 12, 2025
Impact of neighborhood deprivation on bladder cancer outcomes: A regional analysisAnosh Dadabhoy, Chirag Doshi, Mazyar Zahir, et al.Bladder Cancer (Amsterdam, Netherlands)|August 15, 2020
Review of SWOG S1314: Lessons from a Randomized Phase II Study of Co-Expression Extrapolation (COXEN) with Neoadjuvant Chemotherapy for Localized, Muscle-Invasive Bladder CancerPeter Boxley, Melissa Plets, Thomas W FlaigBladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA ExpressionRonald A Lubet, Amit Kumar, Jennifer T Fox, et al.Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction TherapyJean-Françcois Paré, Maryam Tabasinezhad, Arielle Grossman, et al.Bladder Cancer (Amsterdam, Netherlands)|April 29, 2025
Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updatesTakafumi Yanagisawa, Akihiro Matsukawa, Jeremy Yuen-Chun Teoh, et al.Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Repeat TURBT in large volume high-grade non-invasive bladder cancerAdri M Durant, Mimi Nguyen, Mouneeb M Choudry, et al.Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
North American study and meta-analysis evaluating performance of Bladder EpiCheck®, a FDA cleared test, in non-muscle invasive bladder cancer recurrenceNeil Fleshner, Herbert Barton Grossman, Ryan Berglund, et al.Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
BCG therapy for bladder cancer: Exploring patient experiences and concerns through artificial intelligence-based social media analysisZine-Eddine Khene, Isamu Tachibana, Raj Bhanvadia, et al.Bladder Cancer (Amsterdam, Netherlands)|March 4, 2025
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancerAndrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, et al.Pageof 31